Literature DB >> 2010539

The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.

Y Ikeda1, M Handa, K Kawano, T Kamata, M Murata, Y Araki, H Anbo, Y Kawai, K Watanabe, I Itagaki.   

Abstract

Exposure of platelets to shear stress leads to aggregation in the absence of exogenous agonists. We have now found that different adhesive proteins and platelet membrane glycoproteins are involved in aggregation depending on the shear stress conditions and the concentration of divalent cations in the medium. When blood is collected with trisodium citrate as anticoagulant, which causes a decrease in the levels of external ionized calcium ([Ca2+]o), platelet aggregation can be induced under low shear force (12 dyn/cm2) and is mediated by fibrinogen binding to the glycoprotein IIb-IIIa complex. Aggregates formed under these conditions are not stable, and when shear force is increased to 68 dyn/cm2, disaggregation results. By contrast, platelets from blood collected with hirudin as anticoagulant, wherein [Ca2+]o is within normal plasma levels, do not undergo low shear-induced aggregation; however, after exposure to a shear force above 80 dyn/cm2, aggregation is observed but only when von Willebrand factor is present and can interact with both its platelet binding sites, glycoprotein Ib-IX and glycoprotein IIb-IIIa. Fibrinogen is not involved in high shear-induced aggregation which, in fact, occurs normally in patients with severe afibrinogenemia. Thus, von Willebrand factor in the absence of exogenous agonists can mediate platelet aggregation in experimental conditions that may mimic the hemorheological situation of partially occluded arteries. This pathway of platelet aggregation involving only one adhesive ligand and two membrane adhesion receptors may play a relevant role in thrombogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010539      PMCID: PMC295144          DOI: 10.1172/JCI115124

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man.

Authors:  L D Back; J R Radbill; D W Crawford
Journal:  J Biomech       Date:  1977       Impact factor: 2.712

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Human platelets possess an inducible and saturable receptor specific for fibrinogen.

Authors:  G A Marguerie; E F Plow; T S Edgington
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

4.  Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.

Authors:  R L Nachman; L L Leung
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

5.  Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia.

Authors:  B S Coller
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

6.  In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of the cat.

Authors:  H H Lipowsky; S Usami; S Chien
Journal:  Microvasc Res       Date:  1980-05       Impact factor: 3.514

7.  Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin.

Authors:  J F Mustard; R L Kinlough-Rathbone; M A Packham; D W Perry; E J Harfenist; K R Pai
Journal:  Blood       Date:  1979-11       Impact factor: 22.113

8.  Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets.

Authors:  M H Ginsberg; J Forsyth; A Lightsey; J Chediak; E F Plow
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Identification of the fibrinogen receptor on human platelets by photoaffinity labeling.

Authors:  J S Bennett; G Vilaire; D B Cines
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

10.  Platelets have more than one binding site for von Willebrand factor.

Authors:  Z M Ruggeri; L De Marco; L Gatti; R Bader; R R Montgomery
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more
  84 in total

1.  Time and force dependence of the rupture of glycoprotein IIb-IIIa-fibrinogen bonds between latex spheres.

Authors:  H L Goldsmith; F A McIntosh; J Shahin; M M Frojmovic
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

Review 2.  Function and clinical significance of platelet-derived microparticles.

Authors:  S Nomura
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

3.  Nonlinear flow affects hydrodynamic forces and neutrophil adhesion rates in cone-plate viscometers.

Authors:  H Shankaran; S Neelamegham
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

Review 4.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

5.  Carotid turbulent flow observed by convergent color Doppler flowmetry in silent cerebral infarction.

Authors:  Mie Ohyama; Katsufumi Mizushige; Hideo Ohyama; Tsutomu Takahashi; Naohisa Hosomi; Shin-Ichiro Ichihara; Masakazu Kohno
Journal:  Int J Cardiovasc Imaging       Date:  2002-04       Impact factor: 2.357

Review 6.  Recent advances in primary percutaneous intervention for acute myocardial infarction.

Authors:  E J Smith; A Mathur; M T Rothman
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

7.  A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry.

Authors:  M Edward Quach; Anum K Syed; Renhao Li
Journal:  J Vis Exp       Date:  2019-06-05       Impact factor: 1.355

8.  von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure.

Authors:  L Holmberg; J A Dent; R Schneppenheim; U Budde; J Ware; Z M Ruggeri
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.

Authors:  M Murata; S R Russell; Z M Ruggeri; J Ware
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Treatment of mechanical aortic valve thrombosis with heparin and eptifibatide.

Authors:  Amit N Vora; Thomas Gehrig; Thomas M Bashore; Todd L Kiefer
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.